Sales/Maturities of Investments

$7.07B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$7.07Bperiod endingJun 30, 2026

VRTX Sales/Maturities of Investments (-$23.90M → $7.07B)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

VRTX sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	5,913,400,000
Dec 31, 2024	4,465,600,000
Dec 31, 2023	934,200,000
Dec 31, 2022	920,000,000
Dec 31, 2021	499,300,000
Dec 31, 2020	809,909,000
Dec 31, 2019	570,860,000
Dec 31, 2018	431,576,000
Dec 31, 2017	369,214,000
Dec 31, 2016	757,562,000
Dec 31, 2015	1,067,443,000
Dec 31, 2014	1,557,938,000
Dec 31, 2013	2,348,295,000
Dec 31, 2012	1,367,927,000
Dec 31, 2011	1,016,040,000
Dec 31, 2010	1,284,806,000
Dec 31, 2009	788,263,000
Dec 31, 2008	427,648,000
Dec 31, 2007	755,620,000
Dec 31, 2006	302,438,000
Dec 31, 2005	243,410,000
Dec 31, 2004	292,351,000
Dec 31, 2003	593,998,000
Dec 31, 2002	728,037,000
Dec 31, 2001	1,176,186,000
Dec 31, 2000	1,088,582,000
Dec 31, 1999	428,900,000
Dec 31, 1998	495,300,000
Dec 31, 1997	191,000,000
Dec 31, 1996	36,200,000
Dec 31, 1995	38,300,000
Dec 31, 1994	72,300,000
Dec 31, 1993	56,800,000
Dec 31, 1992	31,600,000
Dec 31, 1991	-23,900,000